Cargando…
The human application of gene therapy to re-program T-cell specificity using chimeric antigen receptors
The adoptive transfer of T cells is a promising approach to treat cancers. Primary human T cells can be modified using viral and non-viral vectors to promote the specific targeting of cancer cells via the introduction of exogenous T-cell receptors (TCRs) or chimeric antigen receptors (CARs). This ge...
Autores principales: | Guerrero, Alan D, Moyes, Judy S, Cooper, Laurence JN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190432/ https://www.ncbi.nlm.nih.gov/pubmed/25189715 http://dx.doi.org/10.5732/cjc.014.10100 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023) -
Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
por: Jena, Bipulendu, et al.
Publicado: (2013) -
Chimeric Antigen Receptor T Cell Therapy in Hematology
por: Ataca, Pınar, et al.
Publicado: (2015) -
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022) -
Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
por: Reinhardt, Bryanna, et al.
Publicado: (2023)